-
More than 100 healthcare professionals challenge rejection of psilocybin access
In 2020, Health Canada started granting exemptions under the Controlled Drugs and Substances Actto provide psychedelics treatment to patients suffering from end-of-life psychological distress, treatment-resistant depression and major depressive disorder.